French CAR-T biotech Mnemo Therapeutics shutters US operations
06 Mar 2023
A Sofinnova-backed CAR-T maker has shut down its New York and Princeton, NJ sites and will continue operating out of its Paris hub.
Mnemo Therapeutics turned the lights off at its US operations effective immediately on Feb. 23, according to employees’ posts on LinkedIn and confirmation from co-founder and operating chief Alain Maiore.
“When Sebastian [Amigorena] and I started Mnemo Tx, we were looking to build a company where the human value of ‘standing shoulder to shoulder’ in difficult time would typify the DNA of our teams across the ocean,” Maiore wrote on LinkedIn in recent days. “The decision we had to make about shutting down our US operations, to move back our CT effort to Europe, next to our target discovery platform was a very difficult one.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.